Skip to content
zameds

Atipamezole

Sold as Revazol, Antipam, Alzane, Antisedan

Loading the molecular structure
C14H16N2212.29 g/mol

5-(2-Ethyl-1,3-dihydroinden-2-yl)-1H-imidazole

Drag to rotate. Structure from PubChem CID 71310.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
3
Registrations
4

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Virbac Rsa (Pty) LtdRevazol5 mg/ml13/07Not determinedNone
Kyron Animal Health (Pty) LtdAntipaminjection6-NovNot determinedNone
Zoetis South Africa (Pty) Ltd1 of 2 cancelledAlzane, AntisedanNot stated7-Dec, 92/4Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Revazol injection 5 mg/ml

EACH 1,0 ml SOLUTION CONTAINS ATIPAMEZOLE HYDROCHLORIDE 5,0 mg

5 mg/mlInjection13/0713/1.4.2/07RegisteredNot determinedNone
Antipam injection

EACH 1,0 ml SOLUTION CONTAINS : ATIPAMEZOLE HYDROCHLORIDE 5,0 mg

Injection6-Nov11/1.4.3/06RegisteredNot determinedNone
Alzane

EACH 1,0 ml SOLUTION CONTAINS ATIPAMEZOLE HYDROCHLORIDE 5,0 mg

Not listed7-Dec12/1.4.3/07CancelledNot determinedNone
Antisedan

EACH 1 ml SOLUTION CONTAINS ATIPAMEZOLE HYDROCHLORIDE 5 mg

Not listed92/492/2.2/4RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles